BNP Paribas Financial Markets
ARKG icon

BNP Paribas Financial Markets’s ARK Genomic Revolution ETF ARKG Stock Holding History

BNP Paribas Financial Markets’s Portfolio ARKG Stock Details ARKG Fund Activity
Bought
Maintained
Sold
Quarter Market Value Status Shares Change in
Stake 		Trade Value Portfolio Weight Portfolio Position
2026
Q2 		$73.8M Buy
1,753,957
+259,893
+17% +$8.28M 0.03% 578
2026
Q1 		$39.5M Sell
1,494,064
-2,020,916
-57% -$59.2M 0.02% 785
2025
Q4 		$102M Buy
3,514,980
+1,167,558
+50% +$35M 0.05% 406
2025
Q3 		$65.2M Sell
2,347,422
-295,699
-11% -$7.47M 0.03% 516
2025
Q2 		$64.4M Sell
2,643,121
-148,451
-5% -$3.25M 0.04% 476
2025
Q1 		$58M Buy
2,791,572
+1,253,081
+81% +$31.5M 0.03% 536
2024
Q4 		$36.2M Sell
1,538,491
-1,742,242
-53% -$42.9M 0.02% 753
2024
Q3 		$84M Buy
3,280,733
+1,021,498
+45% +$26M 0.06% 319
2024
Q2 		$53M Sell
2,259,235
-71,338
-3% -$1.8M 0.04% 406
2024
Q1 		$67M Buy
2,330,573
+1,173,872
+101% +$35.3M 0.06% 344
2023
Q4 		$38M Buy
1,156,701
+612,712
+113% +$16.7M 0.04% 457
2023
Q3 		$15.2M Sell
543,989
-1,154,920
-68% -$37.8M 0.02% 724
2023
Q2 		$57.9M Sell
1,698,909
-284,991
-14% -$8.96M 0.07% 256
2023
Q1 		$59.7M Buy
1,983,900
+1,280,246
+182% +$39.7M 0.08% 250
2022
Q4 		$19.9M Sell
703,654
-1,543,013
-69% -$49M 0.03% 662
2022
Q3 		$73.8M Buy
2,246,667
+1,613,999
+255% +$59.3M 0.12% 173
2022
Q2 		$19.9M Buy
632,668
+132,756
+27% +$4.64M 0.03% 583
2022
Q1 		$23M Sell
499,912
-141,551
-22% -$6.75M 0.03% 559
2021
Q4 		$39.3M Buy
641,463
+543,093
+552% +$37.5M 0.06% 367
2021
Q3 		$7.35M Buy
98,370
+18,541
+23% +$1.56M 0.01% 1098
2021
Q2 		$7.38M Sell
79,829
-7,610
-9% -$647K 0.01% 1102
2021
Q1 		$7.76M Buy
87,439
+61,541
+238% +$6.1M 0.01% 940
2020
Q4 		$2.42M Buy
25,898
+25,663
+10,920% +$2.04M ﹤0.01% 1529
2020
Q3 		$15K Buy
+235
New +$13.8K ﹤0.01% 3902

Other funds holding ARKG

JP Morgan Chase
JP Morgan Chase New York $1.81T AUM 41.13% 1-Year Est. Return
Morgan Stanley
Morgan Stanley New York $1.89T AUM 35.08% 1-Year Est. Return
Citigroup
Citigroup New York $303B AUM 53.02% 1-Year Est. Return
UBS Group
UBS Group Zurich, Switzerland $786B AUM 40.34% 1-Year Est. Return
LPL Financial
LPL Financial San Diego, California $445B AUM 25.58% 1-Year Est. Return
MML Investors Services
MML Investors Services Springfield, Massachusetts $49B AUM 25.55% 1-Year Est. Return
NAM
NTV Asset Management Charleston, West Virginia $1.02B AUM 31.16% 1-Year Est. Return
SG Americas Securities
SG Americas Securities New York $179B AUM 65.34% 1-Year Est. Return
MFPI
Midwest Financial Partners Investments St. Cloud, Minnesota $241M AUM
Bank of Montreal
Bank of Montreal Toronto, Ontario, Canada $304B AUM 35.64% 1-Year Est. Return

BNP Paribas Financial Markets's ARKG Position: Q2 2026 in Review

BNP Paribas Financial Markets increased its ARK Genomic Revolution ETF (ARKG) stake by 17% in Q2 2026, buying an estimated $8.28M and bringing the position to 1,753,957 shares worth $73.8M. The position accounts for 0.03% of the portfolio, ranked #578.

BNP Paribas Financial Markets first reported a position in ARKG in Q3 2020 and has held it in 24 quarters since. The position peaked at $102M in Q4 2025. 218 funds tracked by Wall St. Rank hold ARKG as of Q2 2026.

  • BNP Paribas Financial Markets held 1,753,957 shares of ARK Genomic Revolution ETF worth $73.8M as of Q2 2026.
  • BNP Paribas Financial Markets bought 259,893 ARK Genomic Revolution ETF shares in Q2 2026, an estimated $8.28M.
  • ARK Genomic Revolution ETF made up 0.03% of BNP Paribas Financial Markets's portfolio in Q2 2026, its #578 holding.
  • BNP Paribas Financial Markets first reported a position in ARK Genomic Revolution ETF in Q3 2020 and has held it in 24 quarters since.
  • BNP Paribas Financial Markets's ARK Genomic Revolution ETF position peaked at $102M in Q4 2025.
  • 218 funds tracked by Wall St. Rank held ARK Genomic Revolution ETF as of Q2 2026.

Based on BNP Paribas Financial Markets's 13F filing for Q2 2026, filed 13 Aug 2026.